Clinical Microbiology Newsletter
Volume 31, Issue 14 , Pages 103-107, 15 July 2009

Emerging Infections: Implications for Sentinel and Public Health Laboratories

  • James L. Beebe, Ph.D., D(ABMM)

      Affiliations

    • San Luis Obispo County Health Agency, San Luis Obispo, California
    • Corresponding Author InformationMailing address: James L. Beebe, Ph.D., D(ABMM), Director, Public Health Laboratory, San Luis Obispo County Health Agency, 2191 Johnson Ave., P.O. Box 1489, San Luis Obispo, CA 93406. Tel.: 805-781-5512. Fax: 805-781-1023
  • ,
  • Alice S. Weissfeld, Ph.D., D(ABMM), F(AAM)

      Affiliations

    • Microbiology Specialists Incorporated, Houston, Texas

Abstract 

After reading the popular novel, “The Cobra Event,” then U.S. President Bill Clinton, concerned with the prospect of use of a biologic agent against the United States, issued Presidential Directive 39. This executive act resulted in the formation of the Laboratory Response Network (LRN), a structured consortium of clinical, governmental, and public health laboratories. The LRN became operational in August 1999, and though few in the laboratory field noticed its birth, by the fall of 2001 and the anthrax letter events, the alliance of clinical and public health laboratories was becoming a reality. The LRN provided the framework for much closer cooperation between clinical (sentinel) laboratories and their public health counterparts and set the stage for a cooperative approach to the ever-evolving list of emerging infections. Subsequently, the National Laboratory System program has been added to reinforce this framework.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0196-4399(09)00031-2

doi:10.1016/j.clinmicnews.2009.06.003

Clinical Microbiology Newsletter
Volume 31, Issue 14 , Pages 103-107, 15 July 2009